PT233 - JR Rahn - LSD, ADHD, and Decriminalization
Mar 02, 2021•1 hr 14 min
Episode description
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD. www.psychedelicstoday.com
For the best experience, listen in Metacast app for iOS or Android
